To identify metabolic pathways that were perturbed in pancreatic cancer (PC), we investigated gene-metabolite networks by integration of metabolomic and transcriptomic. In this research, we undertook the metabolomic study of 43 paired human PC samples, aiming to identify key metabolic alterations in PC. We also carried out in vitro experiments to validate that the key metabolite cytidine and its related gene ENTPD8 played an important role in PC cell proliferation. We screened out 13 metabolites differentially expressed in PC tissue (PCT) by liquid chromatography/ mass spectrometry analysis on 34 metabolites, and the partial least square discrimination analysis results revealed that 9 metabolites among them were remarkably altered in PCT compared to adjacent noncancerous tissue (variable importance in projection >1, P < .05). Among the 9 metabolites, 7 might be potential biomarkers.
Metabolomic is one of the omics technologies enabling quantification of massive small molecules, termed metabolites, simultaneously. 4 Considering that the metabolome is a close molecular representation of tumor phenotype in cancer, metabolomic might be able to determine clinically relevant metabolomic subclasses. 5 Untargeted MS analysis is a proven universal analysis method, which shows high intra-assay precision and linear detection for the majority of compounds tested. However, because of the massive number of compounds, the technique possesses certain drawbacks in specific detection. 6 Fortunately, targeted metabolomic specialize in measuring a set of known metabolites with high sensitivity and good reproducibility, which could fill the gap of the untargeted experiment. 7 Typically, the detection set was normally hard to define, making the method a dilemma. 8 The parallel application of the two analytical techniques could contribute to absolute quantification of specific metabolites and discover more novel compounds that can serve as diagnostic cancer biomarkers. Cho et al 9 revealed urinary biomarkers for discriminating obese from normal-weight adolescents by combining untargeted and targeted metabolomic profiling. Shang et al 10 unveiled three significantly abundant metabolites, galactinol, melibiose, and melatonin, in papillary thyroid cancer and validated these potential diagnostic biomarkers using gas chromatography-TOF-MS-based targeted and untargeted metabolomic approaches. Transcriptomic is another omics technology that analyzes all RNA molecules transcribed from DNA in cells, tissues, or organs. 11 Combined with transcriptomic, systematic investigation of metabolomic data can be largely enhanced by linking known metabolites and genes through their shared metabolic pathways. 4 Recently, researchers have taken advantage of the integration of metabolomic and transcriptomic to study the perturbed metabolic pathways in carcinomas, such as pancreatic ductal adenocarcinoma, 12 prostate cancer 13 , and clear cell renal cell carcinoma. 14 With the application of various emerging methods and materials in fields, more specific biomarkers were revealed.
Pyrimidine is an aromatic heterocyclic organic compound similar to pyridine, and pyrimidine biosynthesis occurs both in the body and through organic synthesis. As a pyrimidine component of RNA, cytidine has been found to control neuronal-glial glutamate cycling, with supplementation decreasing midfrontal/cerebral glutamate/glutamine levels. 15 Cytidine triphosphate is a pyrimidine nucleoside triphosphate acting as an inhibitor of the enzyme aspartate carbamoyltransferase, which is used in pyrimidine biosynthesis. Nucleoside triphosphate diphosphohydrolases are omnipresent enzymes for hydrolyzing nucleoside triphosphates and nucleoside diphosphates, and they have an extra plasmic orientation. 16 In the ENTPD family, ENTPD8 is the latest member to be discovered and characterized; it is a transmembrane protein that regulates the concentration of the agonists of P1 and P2 receptors at the cell surface. 17 In this study, we aimed to identify both metabolic biomarkers and metabolic pathways that had been perturbed in PC by integration of metabolomic and transcriptomic. We screened the differentially expressed metabolite cytidine and its related gene ENTPD8 in PC and we verified in vitro that the CTP dephosphorylation pathway in PC was altered.
| MATERIALS AND METHODS

| Patients and tissue collection
After acquiring written informed consent and approval, including acknowledging purposes, contents, and risks, 43 matched pancreatic tumor and ANTs were collected from patients with PC after surgery at the Third Affiliated Hospital of Soochow University (Changzhou, China). Detailed information of patients is available in Table 1 .
Eighty-six tissue samples consisting of 43 pairs of PCTs and ANT were covered in this study, coming from 23 men and 20 women.
The average age of patients was 67.9 years (range, 43.2-85.7 years).
Medical histories of all these patients were recorded, and no diabetic patients were found. There was no chemotherapy or radiotherapy prior to the examination. Tissues for this study were flash frozen after surgery and stored at −80°C before metabolomic characterization. The use of tissue samples was agreed by the ethics committee of the Third Affiliated Hospital of Soochow University. All the experimental procedures were approved by the Third Affiliated Hospital of Soochow University, and they conform with the provisions of the Declaration of Helsinki. 
| Chemicals and reagents
| Sample collection
For each specimen, 10 mg wet tissue was weighed and placed into a 2-mL centrifuge tube. A porcelain ball and 300 μL ice-cold methanol with internal standards were added, followed by homogenization in a frozen mixed ball grinding machine. Next, 0.4 mL acetonitrile solution with 0.2% formic acid was added, and the mixture was incubated at 4°C for 30 minutes, followed by centrifugation for 3 minutes (15 000 g, 4°C). Lipids and hydrophobic metabolites were primarily distributed into the upper layer, and then transferred into a clean centrifuge tube and stored at −80°C. 
| Liquid chromatography-MS analysis
Liquid chromatography-MS analysis was carried out with a ultra and are shown in Table 2 . All reactions were carried out using an Applied Rotor-Gene 6000 Real-Time PCR System (Corbett Research, Mortlake, Vic., Australia) in triplicate. Data from real-time PCR were analyzed using the 2 ÀΔΔCt method.
| Immunohistochemical analysis
Tissues obtained from the same study cohorts in the metabolites analysis were fixed in neutral-buffered 10% formalin solution, embedded in paraffin, and sectioned at a thickness of 4 μm. Sections were rehydrated and incubated with 3% H 2 O 2 methanol for 10 minutes, 10% goat serum for 30 minutes at room temperature, 50 μL primary antibodies (ENTPD8 antibodies; Saierbio, Tianjin, China) at 4°C overnight, 40-50 μL secondary antibodies at room temperature for 1 hour, and then peroxidase-conjugated streptavidin at 37°C for 30 minutes. Sequentially, DAB used for staining was added for 5-10 minutes, and then sections were washed in water. Finally, sections were rapidly dehydrated in graded ethanol, cleared in Xylene, and mounted with neutral gum for observation.
| Western blot analysis
The cells were dissolved in RIPA, and the concentration was determined using a BCA Protein Assay Kit (Beyotime Biotechnology, Shanghai, China). Fifty micrograms of protein for each sample was separated on 4%-12% NuPAGE gel with MOPS SDS running buffer (Thermo Fisher Scientific) and transferred to a PVDF membrane. After being blocked for 30 minutes at room temperature, membranes were probed with primary antibodies (rabbit anti-human β-actin, ENTPD8 antibodies;
Beyotime Biotechnology) and GAPDH overnight at 4°C and washed four times with 1× TBST. Sequentially, HRP-conjugated anti-rabbit secondary antibody (ZSBIO, Beijing, China) was diluted and incubated with membranes for 4 hours at room temperature, and then washed four times with 1× TBST. Finally, rinsed PVDF membranes were placed in a dark room, and electrochemiluminescent was then used for staining.
Immunoreactive bands of the protein expression were normalized to the intensity of the corresponding bands for β-actin.
| Cell culture
Human pancreatic cancer cell lines PANC-1 and CFPAC-1 were purchased from the cell bank of the Chinese Academy of Sciences (Shanghai, China). PANC-1 cells were incubated in DMEM supplemented with 10% FBS and 1.5 g/L NaHCO 3 . CFPAC-1 cells were grown in DMEM with 10% FBS. All the cells were cultured at 37°C with 5% CO 2 .
| Cell transfection
An NC group of scrambled siRNA and an experimental group of si-ENTPD8 were designed by BLOCK-iT RNAi Designer Software (Invitrogen), and the sequences are shown in Table 3 . Plasmid pcDNA3.1 
| Flow cytometry assay
| Cell metabolite detection
Cells were quenched with 12 mL ice-cold 0.9% (w/v) NaCl for 5 minutes, then the mixture was transferred into a centrifuge tube by pipetting and centrifuged at 15 000 g for 3 minutes at −19°C, and the supernatant was discarded. Five milliliters of 50% methanol was added to the tube and vortex-mixed for 10 seconds and then transferred into the liquid nitrogen and submerged for 3 minutes. Samples were thawed for 5 minutes at room temperature and then vortexmixed for 10 seconds. The procedure was repeated twice, and the samples were centrifuged at 21 000 g for 5 minutes at 4°C, and the supernatant was ready for LC-MS analysis.
| Statistical analysis
Online were quantified and we evaluated the levels of these compounds (Table S2 ). Among them, 13 kinds of metabolites were differentially expressed in PCT compared to ANT (P < .05; FDR < 0.05; Table 4 ), including 7 upregulated metabolites, such as 2-hydroxybutyrate, isoleucine, and taurine, and 6 downregulated metabolites, such as adenosine, 3-methylhistidine, and cytidine. Among all these metabolites, cytidine showed a significant decrease in PCT according to the logFC value in Table 4 . The relative levels of metabolites in PCT and ANT were visualized on a heat map ( Figure 1A ).
| Metabolic biomarkers of PC were confirmed using PLS-DA model
Partial least square discrimination analysis is a supervised partial least squares analysis mainly used to find potential biomarkers by analyzing metabolic differences from massive data. Data of 34 The model quality was measured by R 2 and Q 2 value, R 2 = 0.79, Q 2 = 0.71. In Figure 1 (B), each data point on the graph represents an independent sample, and the ellipse represents the 95% confidence interval. Variable importance in projection score indicators are mainly used to describe the weight of independent variables in the interpretation of the dependent variable. The greater the VIP score is, the greater the impact on PC1 is. According to the VIP scores, cytidine was supposed to have the largest impact on PC1, which might be a new biomarker. In this study, metabolites with VIP > 1 as well as P < .05 were screened as metabolic biomarkers. Nine metabolic biomarkers with the most contributions to PC1 were screened out ( Figure 1C) . Combined with the t test, 7 biomarkers were screened out, including cytidine, 2-hydroxybutyrate, adenosine, 3-methylhistid, acetylcholine, isoleucine, and betaine.
| Integrated metabolic and transcriptomic analyses suggested major altered pathways in PC
To trace the upstream metabolic pathways of metabolic biomarkers, metabolite sets enrichment analysis was carried out using Metaboan- Figure 2B . We matched the pyrimidine pathways to the KEGG database, and KEGG pathway maps collected related genes of manually drawn pathways, from which we obtained 290 corresponding mRNAs. By intersection, we found that ENTPD8 existed in both mRNA sets coming from KEGG and TCGA ( Figure 2C ). Moreover, according to KEGG, there was a correlation between ENTPD8 and metabolic biomarker cytidine in the pyrimidine metabolism ( Figure 2D ). The remaining genes on this metabolic pathway, such as CTPS1, CTPS2, ENTPD1, ENTPD2, and NT5E, had no statistical difference under the conditions of P < .05, FDR < 0.05. We confirmed that both cytidine and ENTPD8 were downregulated in PCT, and ENTPD8, which catalyzed formation of cytidine, was encoded by ENTPD8 mRNA. Hence, we hypothesized that CTP dephosphorylation in PCT was weakened.
| ENTPD8 downregulated in PCT compared to ANT
To validate our hypothesis, qRT-PCR was undertaken to measure the expression level of ENTPD8 mRNA. We found that the relative expression of ENTPD8 mRNA in PCT was lower than that in ANT (P < .05; Figure 3A) . Furthermore, results of immunohistochemical assay and Western blot analysis revealed that the relative expression of ENTPD protein was also downregulated in PCT compared with ANT ( Figure 3B,C) . In short, ENTPD8 and its protein had lower expression levels in PCT compared to ANT. 
T A B L E 4 T test of all metabolites expressed in pancreatic cancer tissue (PCT) according to liquid chromatography-mass spectrometry analysis
| Overexpression of ENTPD8 suppressed cell viability and promoted cell apoptosis in PCT
The expression level of ENTPD8 was quantified by qRT-PCR assay after transfection. The expression of ENTPD8 was higher in the overexpression group, and the expression of ENTPD8 in si-groups was lower than NC (P < .001; Figure 4A ). ENTPD8 protein expression was confirmed to be upregulated in the ENTPD8 group and downregulated in si-ENTPD8 group by Western blot after transfection ( Figure 4B ). The CCK-8 assay then showed a strengthened cell viability in the si-ENTPD8 group at 72 hours but a weakened cell viability in the ENTPD8 group, indicating that ENTPD8 could inhibit PC cell viability (P < .05, Figure 4C ). Additionally, flow cytometry results ( Figure 5A) revealed a higher apoptosis rate in the ENTPD8 group compared to the NC group (P < .01; Figure 5B ), whereas the apoptosis rate was attenuated after transfection with si-ENTPD8 (P < .05; Figure 5B ), indicating that ENTPD8 could promote cell apoptosis in PCT.
| ENTPD8 affected the amount of CTP, CMP, and cytidine
The cell metabolites analysis revealed that overexpression of ENTPD8 could downregulate the amount of CTP, while the amount of CMP and cytidine was upregulated. The amount of CTP was upregulated when ENTPD8 was knocked down and the amount of CMP and cytidine was at a lower level (all P < .05; Figure 5C -E). We supposed that ENTPD8 could catalyze the dephosphorylation of CTP to CMP in the pyrimidine metabolism pathway and the amount of cytidine relied on the amount of CMP because it was dephosphorylated by CMP according to the metabolism pathway. In conclusion, the expression of ENTPD8 can affect the amount of these three metabolites.
| DISCUSSION
It is well recognized that metabolomic can provide snapshots of physiological conditions in biological samples by acquiring qualitative and quantitative information of low-molecular-mass endogenous metabolites, 18 and it has been applied to identify potential molecular biomarkers of various cancers. [19] [20] [21] A previous study suggested that malignant cancers had markedly altered intermediate metabolites in metabolic pathways compared with nontumor tissue. 22 In addition, Budhu et al 23 found that metabolic profiles were significantly different among several cancer types, and those distinct metabolites or metabolic pathways in particular cancer types might be helpful to atic ductal adenocarcinoma. 12 Herein, we screened 13 altered metabolites in PCT by LC-MS metabolomic and the PLS-DA model, and found that these altered metabolites were mainly enriched in pyrimidine metabolism. By analyzing both metabolomic and transcriptomic data, only one gene, ENTPD8, was found to be not only differentially expressed in PCT but also involved in the altered metabolic pathway. According to our findings, we hypothesized that CTP dephosphorization in pyrimidine metabolism was altered in PCT.
The ENTPD family was hypothesized to associate with inflammation and reactive oxygen species, which are related to cancer to some extent; for instance, ENTPD8, ENPP2, and ENPP3 were downregulated after calving. 27 Moreover, ENTPD8 has been identified as a key regulator gene in chicken metabolism with the application of chicken time series microarray data. 28 In the present study, we combined metabolomic with transcriptomic to conjointly analyze the altered metabolic pathways in PCT compared with normal tissues, and we investigated the mechanism of the altered metabolite cytidine and its related gene ENTPD8 in PC for the first time. 
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